Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

MAb from Hayashibara with IFN-inducing properties

Jan. 23, 1997

Raloxifene for inhibition of vascular smooth muscle cell migration

Jan. 23, 1997

Glaxo Wellcome claims new formulation of anxiolytic agent

Jan. 23, 1997

New antiasthma agents from Tanabe Seiyaku

Jan. 23, 1997

5-HT3/5-HT4 receptor ligands disclosed by Synthelabo

Jan. 23, 1997

SmithKline Beecham reports new antiinflammatory/antiallergic agents

Jan. 23, 1997

New COX-2 inhibitor series disclosed by Merck Frosst

Jan. 23, 1997

ACAT inhibitors from Takeda

Jan. 23, 1997

Cell adhesion inhibitors claimed by Nippon Shinyaku

Jan. 23, 1997

Toyama discloses antiplatelet agents

Jan. 23, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.